Integromics, a leader in IT solutions provision for life sciences in the field of genomics and proteomics, today announced the publication of a paper in the journal Cell highlighting a novel genome wide profiling of polyadenylation events in human and yeast performed with Direct RNA Sequencing.
The data analysis used the recently introduced SeqSolve Next Generation Sequencing (NGS) functional bioinformatics analysis software and Direct RNA Sequencing. The discovered novel polyadenylation genomic sites and signals will provide a unique reference resource for the scientific community.
The published results demonstrate the crucial importance of appropriate bioinformatics software in maximizing the value of the data produced by high-end last generation high-throughput sequencing instruments. This is important in a market environment, where the cost of sequencing is plummeting, but the revolution is limited by a bottleneck at the level of downstream functional data analysis and interpretation.
The online portal to the latest developments in laboratories and laboratory equipment
Showing posts with label Integromics SL. Show all posts
Showing posts with label Integromics SL. Show all posts
Monday, 10 January 2011
Monday, 29 November 2010
Management and analysis of mass spectrometry data
Integromics, a leader in IT solutions provision for life sciences in the field of genomics and proteomics, today announces that the Princeton Mass Spectrometry Center has purchased a license for the Integromics’ OmicsHub Proteomics solution.
The Princeton University Center will use OmicsHub as a key element in its strategy for data management and analysis of mass spectrometry (MS) data. Integromics will deploy the solution at Princeton and create a functional data analysis infrastructure by the end of 2010.
The Princeton University Center will use OmicsHub as a key element in its strategy for data management and analysis of mass spectrometry (MS) data. Integromics will deploy the solution at Princeton and create a functional data analysis infrastructure by the end of 2010.
Labels: laboratory, drug discovery
Integromics SL
Subscribe to:
Posts (Atom)